Halaman 6 - Kemoterapi Dokter Terbaik - TOP-159 dokter

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Direktur Klinis Unit Payudara Multidisiplin dengan 322 publikasi peer-review – Dr. Kuemmel memimpin penelitian kanker payudara di Kliniken Essen-Mitte.

• Anggota Dewan Eksekutif AGO (Arbeitsgemeinschaft Gynäkologische Onkologie)
• Anggota Fakultas ESMO untuk Kanker Payudara
• PI Global dan kepala 27 investigasi dan uji klinis
• Anggota dari berbagai perkumpulan onkologi bergengsi termasuk ESMO dan ASCO

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Pakar terkemuka dalam leukemia limfositik kronis (LLK) – Profesor Bosch telah merintis pengobatan dan teknologi baru untuk penyakit hematologi.

• Melakukan lebih dari 80 uji klinis dari fase 1 hingga fase 3
• Menerbitkan lebih dari 100 artikel di jurnal medis terkemuka
• Kepala Hematologi di IOB Institute of Oncology
• Presiden kelompok Spanyol untuk studi LLK (GELLC)

Peneliti Utama dalam uji klinis untuk kanker ovarium, serviks, dan endometrium – Dr. Oaknin memimpin penelitian terobosan di Hospital Quiron Barcelona.

• Penulis 100+ publikasi tentang tumor ginekologi
• Anggota dewan eksekutif Kelompok GEICO (Kelompok Penelitian Kanker Ovarium Spanyol)
• Anggota fakultas untuk Gyn-Track di ESMO
• Perwakilan Spanyol dalam Komite Serviks Kelompok GCIG

Berspesialisasi dalam pengobatan kanker payudara dan melanoma, berfokus pada resistensi terapi hormon dan imunoterapi. Bekerja di Hospital Quiron Barcelona.

• Berpartisipasi dalam uji klinis yang mengarah pada persetujuan obat baru untuk kanker payudara
• Terlibat dalam studi yang merevolusi pengobatan melanoma
• Anggota Unit Kanker Payudara dan Melanoma di Vall d’Hebron
• Berfokus pada perawatan pasien yang holistik

Dr. Prat memimpin SOLTI sebagai presiden, merancang uji klinis untuk pengobatan kanker payudara. Penelitiannya berfokus pada ekspresi gen dan subtipe molekuler.

• Kepala Genomik Translasi dan Terapi Bertarget di IDIBAPS
• Salah satu pendiri Reveal Genomics, memegang tiga paten
• Lebih dari 160 publikasi dengan Indeks H 51
• Fellowship onkologi medis di Vall d´Hebron Institute of Oncology
• Profesor Jalur Karier Tetap (Tenure-Track) di Universitas Barcelona

Dr. Graus adalah ahli terkemuka dalam sindrom neurologis paraneoplastik, setelah mendefinisikan kriteria diagnostik ketat pertama untuk kondisi-kondisi ini.

• Pengalaman lebih dari 40 tahun dalam neuro-onkologi
• Mantan Kepala Neurologi di Hospital Clinic Barcelona
• Pendiri dan mantan presiden Asosiasi Neuro-Onkologi Eropa
• Berspesialisasi dalam neurotoksisitas akibat pengobatan kanker
• Gelar doktor kehormatan dari Universitas Lyon

Berspesialisasi dalam onkologi ginekologi dan kemoterapi di Samsung Medical Center.

• Keahlian terfokus pada kanker ginekologi dan pengobatan kemoterapi
• Bekerja di Samsung Medical Center, institusi layanan kesehatan terkemuka
• Onkoginekolog dengan latar belakang kuat dalam perawatan kanker wanita

Spesialis terkemuka Israel dalam imunoterapi kanker paru-paru – Prof. Peled mengepalai Unit Kanker Toraks di Pusat Kanker Davidoff.

• Menyelesaikan pelatihan Fellowship dalam kanker paru-paru di University of Colorado Denver
• Menerima penghargaan MERIT dari American Society of Clinical Oncology (ASCO)
• Memimpin Komite Deteksi Dini & Pencegahan IASLC
• Berspesialisasi dalam pengobatan personalisasi dan imunoonkologi untuk kanker paru-paru

Spesialis radioterapi dengan fokus khusus pada onkologi di Pusat Medis Rambam.

• Berspesialisasi dalam pengobatan kemoterapi dan radioterapi
• Bekerja di Pusat Medis Rambam, institusi layanan kesehatan terkemuka
• Berkomitmen pada rencana perawatan kanker yang dipersonalisasi

Pakar onkologi pediatrik yang diakui secara internasional – Prof. Ben-Harush memimpin Divisi Pediatri di Rumah Sakit Anak Ruth Rappaport.

• Berspesialisasi dalam onkologi pediatrik dan transplantasi sumsum tulang
• Penerima penghargaan Chevalier de la Legion d'Honneur di Prancis
• Dinobatkan sebagai salah satu dokter paling peduli di dunia oleh Asosiasi Medis Dunia
• Anggota kelompok onkologi anak di Amerika Serikat dan Eropa

Kepala Pusat Pengobatan Kanker Payudara – Prof. Jablonski-Perec membawa puluhan tahun keahlian khusus ke Hadassah Medical Center.

• Menerima pelatihan medis di Sloan-Kettering Cancer Center di New York
• Guru Besar (Profesor) Onkologi di Hebrew University sejak 2006
• Mantan Kepala Institut Onkologi
• Anggota dari berbagai perkumpulan kanker internasional

Dr. Spielberg adalah seorang onkohematolog spesialis yang merawat pasien di Pusat Medis Assuta.

• Fokus secara eksklusif pada perawatan kemoterapi
• Bekerja di salah satu pusat medis terkemuka di Israel
• Berdedikasi pada rencana perawatan yang dipersonalisasi untuk setiap pasien

Prof. Madya Murat Ayhan memimpin penelitian kemoterapi mutakhir di Liv Hospital Vadistanbul, dengan berbagai uji klinis internasional.

• Berspesialisasi dalam kanker payudara, paru-paru, dan kolorektal
• Aktif dalam uji klinis Fase II dan III untuk pengobatan baru
• Telah mempublikasikan 25+ makalah penelitian di jurnal onkologi yang ditinjau sejawat
• Anggota ESMO dan Turkish Society of Medical Oncology (Perhimpunan Onkologi Medis Turki)